The primary focus of DIALECTIC THERAPEUTICS is the advancement of novel technologies for combating cancer. The company is committed to alleviating the distress of cancer patients, providing them with optimism, and extending their productive lives through targeted therapies with minimal toxicities and complications. Dialectic Therapeutics (DT) is a pioneering biotechnology organization that is devoted to creating distinctive and potent anti-cancer medications to effectively address the needs of patients with limited treatment options.